false0000310764 0000310764 2020-03-31 2020-03-31 0000310764 syk:SeniorUnsecuredNotes2.125Due2027Member 2020-03-31 2020-03-31 0000310764 syk:SeniorUnsecuredNotes2.625Due2030Member 2020-03-31 2020-03-31 0000310764 syk:SeniorUnsecuredNotes0.250Due2024Member 2020-03-31 2020-03-31 0000310764 syk:SeniorUnsecuredNotes0.750Due2029Member 2020-03-31 2020-03-31 0000310764 syk:SeniorUnsecuredNotes1.125Due2023Member 2020-03-31 2020-03-31 0000310764 us-gaap:CommonStockMember 2020-03-31 2020-03-31 0000310764 syk:SeniorUnsecuredNotesVariableInterestRateDueNovember2020Member 2020-03-31 2020-03-31 0000310764 syk:SeniorUnsecuredNotes1.000Due2031Member 2020-03-31 2020-03-31


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 31, 2020
 
STRYKERLOGOA75.JPG
STRYKER CORPORATION
(Exact name of registrant as specified in its charter)
Michigan
 
001-13149
 
38-1239739
(State of incorporation)
 
(Commission File Number)
 
(I.R.S. Employer Identification No.)
 
 
 
 
 
 
 
 
2825 Airview Boulevard,
Kalamazoo,
Michigan
 
49002
(Address of principal executive offices)
 
(Zip Code)
 
 
 
 
 
 
 
 
 
 

(269)

385-2600
 
 
(Registrant’s telephone number, including area code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
Trading Symbol(s)
 
Name of each exchange on which registered
Common Stock, $.10 Par Value
 
SYK
 
New York Stock Exchange
1.125% Notes due 2023
 
SYK23
 
New York Stock Exchange
0.250% Notes due 2024
 
SYK24A
 
New York Stock Exchange
2.125% Notes due 2027
 
SYK27
 
New York Stock Exchange
0.750% Notes due 2029
 
SYK29
 
New York Stock Exchange
2.625% Notes due 2030
 
SYK30
 
New York Stock Exchange
1.000% Notes due 2031
 
SYK31
 
New York Stock Exchange
Floating Rate Notes due 2020
 
SYK20A
 
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth Company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    





ITEM 7.01
REGULATION FD DISCLOSURE

Stryker Corporation is withdrawing its first quarter and full year 2020 organic sales growth and earnings per share guidance, originally disclosed on January 28, 2020. As the COVID-19 pandemic expands, unprecedented measures to slow the spread of the virus have been taken by local governments and health care authorities globally, including the deferral of elective medical procedures and social contact restrictions, which have had, and we expect will continue to have, a significant negative impact on Stryker’s operations and financial results. Due to the uncertain scope and duration of the pandemic, and uncertain timing of global recovery and economic normalization, Stryker is unable to estimate the overall impacts on its operations and financial results, which could be material. Stryker plans to provide additional information in its next earnings release and conference call, currently scheduled for April 30, 2020.

Caution Concerning Forward-Looking Statements
 
This Form 8-K contains information that includes or is based on forward-looking statements within the meaning of the federal securities laws that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Such statements include, but are not limited to, those regarding our financial performance and the impact of the COVID-19 outbreak on our operations and financial results and are subject to, among other risks, the COVID-19 pandemic and any related policies and actions by governments or other third parties.
 
Additional information concerning these and other factors is contained in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q that we have filed or will file hereafter. We disclaim any intention or obligation to publicly update or revise any forward-looking statement to reflect any change in our expectations or in events, conditions or circumstances on which those expectations may be based, or that affect the likelihood that actual results will differ from those contained in the forward-looking statements.

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
STRYKER CORPORATION
 
 
 
(Registrant)
 
 
 
 
 
 
 
 
Date:
March 31, 2020
 
/s/ GLENN S. BOEHNLEIN
 
 
 
Glenn S. Boehnlein
 
 
 
Vice President, Chief Financial Officer


Stryker (NYSE:SYK)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Stryker Charts.
Stryker (NYSE:SYK)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Stryker Charts.